Efficacy and Safety of Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiovascular Autonomic Neuropathy: Systematic Review and Meta-Analysis (Q28972373)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 12 February 2014)

Language	Label	Description	Also known as
English	Efficacy and Safety of Aldose Reductase Inhibitor for the Treatment of Diabetic Cardiovascular Autonomic Neuropathy: Systematic Review and Meta-Analysis	scientific article (publication date: 12 February 2014)

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

systematic review

1 reference

1 reference

1 reference

26 July 2022

Efficacy and safety of aldose reductase inhibitor for the treatment of diabetic cardiovascular autonomic neuropathy: systematic review and meta-analysis (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

cardiovascular disease

1 reference

2 October 2019

diabetic neuropathy

1 reference

2 October 2019

aldose reductase

1 reference

28 September 2019

enzyme inhibitor

1 reference

20 January 2021

autonomic neuropathy

1 reference

based on heuristic

inferred from abstract

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Xin Hu

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Shengbing Li

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Hua Liu

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Guenther Boden

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Ling Li

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

0 references

publication date

12 February 2014

10 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pmc&retmode=json&id=3922720

20 March 2017

14 March 2019

24 March 2019

25 April 2019

17 June 2019

28 September 2019

2 October 2019

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

20 January 2021

26 July 2022

10 references

14 March 2019

24 March 2019

25 April 2019

17 June 2019

28 September 2019

2 October 2019

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

20 January 2021

26 July 2022

9

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pmc&retmode=json&id=3922720

20 March 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

e87096

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pmc&retmode=json&id=3922720

20 March 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

2

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pmc&retmode=json&id=3922720

20 March 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

copyright license

Creative Commons Attribution 4.0 International

8 references

Europe PubMed Central

14 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

25 April 2019

Europe PubMed Central

17 June 2019

Europe PubMed Central

28 September 2019

Europe PubMed Central

2 October 2019

Europe PubMed Central

20 January 2021

Europe PubMed Central

26 July 2022

copyright status

0 references

on focus list of Wikimedia project

0 references

Aldose reductase inhibitors for the treatment of diabetic polyneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

20 March 2017

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

20 March 2017

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

20 March 2017

Quantifying heterogeneity in a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

20 March 2017

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

20 March 2017

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

20 March 2017

Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-controlled double-blind study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

20 March 2017

Meta-analysis in clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

20 March 2017

Diabetic cardiovascular autonomic neuropathy: clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

The ECG vertigo in diabetes and cardiac autonomic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Autonomic testing: common techniques and clinical applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Cardiac autonomic neuropathy in diabetes: a clinical perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Cardiac autonomic diabetic neuropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Diabetic neuropathy: mechanisms to management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Diabetic cardiovascular autonomic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Clinical potential of aldose reductase inhibitors in diabetic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Cardiac autonomic neuropathy in the diabetic patient: does 123I-MIBG imaging have a role to play in early diagnosis?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Aldose reductase structures: implications for mechanism and inhibition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Diabetic autonomic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Polyol pathway and diabetic peripheral neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Progression rates of diabetic neuropathy in placebo patients in an 18-month clinical trial. Ponalrestat Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Effect of the aldose reductase inhibitor, ponalrestat, on diabetic neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

A 12-Month Randomized Controlled Study of the Aldose Reductase Inhibitor Ponalrestat in Patients with Chronic Symptomatic Diabetic Neuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Long-term effects of tolrestat on symptomatic diabetic sensory polyneuropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomic nervous system testing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3922720

3 June 2018

Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0087096

21 January 2018

Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0087096

21 January 2018

Tolrestat in the Primary Prevention of Diabetic Neuropathy

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0087096

21 January 2018

Aldose reductase inhibition in diabetic neuropathy: clinical and neurophysiological studies of one year's treatment with sorbinil

1 reference

https://pubmed.ncbi.nlm.nih.gov/24533052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24533052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/24533052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24533052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of cardiovascular autonomic function tests: 10 years experience in diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24533052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolrestat for Mild Diabetic Neuropathy: A 52-Week, Randomized, Placebo-Controlled Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/24533052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment: Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://pubmed.ncbi.nlm.nih.gov/24533052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effect of epalrestat on cardiac autonomic neuropathy in subjects with non-insulin dependent diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24533052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variance imputation for overviews of clinical trials with continuous response

1 reference

https://pubmed.ncbi.nlm.nih.gov/24533052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24533052

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0087096

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pmc&retmode=json&id=3922720

20 March 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

2014PLoSO...987096H

0 references

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pmc&retmode=json&id=3922720

20 March 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pmc&retmode=json&id=3922720

20 March 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24533052%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28972373&oldid=1731896516"